AIC
IMMU

Archer Investment Corporation’s Immunomedics Inc IMMU Stock Holding History

Archer Investment Corporation’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-500
Closed -$7K – 674
2020
Q1 		$7K Hold
500
– – ﹤0.01% 460
2019
Q4 		$11K Hold
500
– – 0.01% 447
2019
Q3 		$7K Hold
500
– – ﹤0.01% 373
2019
Q2 		$7K Hold
500
– – ﹤0.01% 366
2019
Q1 		$10K Hold
500
– – 0.01% 342
2018
Q4 		$7K Buy
+500
New +$9.93K 0.01% 339

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Archer Investment Corporation's IMMU Position: Q2 2020 in Review

Archer Investment Corporation sold out of Immunomedics Inc (IMMU) in Q2 2020, closing a stake of 500 shares — an estimated $7K sold.

Archer Investment Corporation first reported a position in IMMU in Q4 2018 and held it in 6 quarters. The position peaked at $11K in Q4 2019. 313 funds tracked by Wall St. Rank hold IMMU as of Q2 2020.

  • Archer Investment Corporation reported no remaining Immunomedics Inc position as of Q2 2020 after selling out during the quarter.
  • Archer Investment Corporation sold 500 Immunomedics Inc shares in Q2 2020, an estimated $7K.
  • Archer Investment Corporation first reported a position in Immunomedics Inc in Q4 2018 and held it in 6 quarters.
  • Archer Investment Corporation's Immunomedics Inc position peaked at $11K in Q4 2019.
  • 313 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2020.

Based on Archer Investment Corporation's 13F filing for Q2 2020, filed 13 Aug 2020.